Anzeige
Erschienen in:
01.05.2005 | Original
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression
Erschienen in: Intensive Care Medicine | Ausgabe 5/2005
Einloggen, um Zugang zu erhaltenAbstract
Objective
Calcium desensitization plays an important part in the pathophysiology of septic myocardial depression. We postulated that levosimendan, a new calcium sensitizer, would be beneficial in sepsis-induced cardiac dysfunction.
Design and setting
Prospective, randomized, controlled study in two university hospital intensive care units
Patients and participants
Twenty-eight patients with persisting left ventricular dysfunction related to septic shock after 48 h of conventional treatment including dobutamine (5 µg/kg per minute).
Interventions
After 48 h of conventional treatment patients were randomized to receive a 24-h infusion of either levosimendan (0.2 µg/kg per minute, n=15) or dobutamine (5 µg/kg per minute, n=13).
Measurements and results
Data from right heart catheterization, echocardiography, gastric tonometry, laser-Doppler flowmetry, and lactate concentrations and creatinine clearance were obtained before and after the 24-h drug infusion. Dobutamine did not change systemic or regional hemodynamic variables. By contrast, at the same mean arterial pressure levosimendan decreased pulmonary artery occlusion pressure and increased cardiac index. Levosimendan decreased left ventricular end-diastolic volume and increased left ventricular ejection fraction. Levosimendan increased gastric mucosal flow, creatinine clearance, and urinary output while it decreased lactate concentrations.
Conclusions
These findings show that levosimendan improves systemic hemodynamics and regional perfusion in patients with septic cardiac dysfunction under conditions where administration of 5 µg/kg dobutamine per minute is no longer efficacious. Accordingly, our results suggest that levosimendan can be an alternative to the strategy of increasing the dose of dobutamine under such conditions.